Webinar – The bigger picture in atherothrombosis: Thinking beyond atrial fibrillation
In this 40-minute webinar recording, Dr Steven Coombs discusses the bigger picture in atherothrombosis and anticoagulation, addressing the following topics:
- Clinical data and real-world evidence surrounding the use of anticoagulation in NVAF
- Considerations when treating patients for whom anticoagulation is more complex
- The importance of appropriate dosing and implications of under- and -overdosing
- The prevention of cardiovascular events in patients with CAD and / or symptomatic PAD
This webinar was recorded in November 2019. This was a promotional webinar intended for UK Healthcare Professionals that was organised and fully funded by Bayer plc.
We are regularly updating our website with new resources to support you and your patients. Please click here to subscribe to receive electronic communications about Bayer’s products, services and events.
To access the latest version of the Xarelto 2.5mg, 10mg and 15/20 mg Summary of Product Characteristics (SmPC) as well as Xarelto Patient Information Leaflet (PIL), please click on the following link eMC Widget
Reporting adverse events and quality complaints
This medicine is subject to additional monitoring. This will allow quick identification of new safety information.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.
If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 0118 206 3500 or Email: firstname.lastname@example.org
Further information is available on the "contact" tab at www.bayer.co.uk.